sameAs
Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by SurgerySafety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the LungDepsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue SarcomaGemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS)Efficacy of 1540 Nanometer Erbium Glass Laser to Improve Benign DermatofibromasAngiomatoid Fibrous Histiocytoma: a Single Institution Case-seriesRadiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by SurgeryA Study of Bevacizumab in Combination With Chemotherapy for Treatment of OsteosarcomaStudy to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid TumorsSpanish Registry of Mohs SurgeryInternational Rare Histiocytic Disorders Registry (IRHDR)Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma SubtypesAZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue SarcomaEffects of Preoperative Physical Therapy in Patients With Lower Extremity MalignancyOptical Biopsy of Human Skin in Conjunction With Laser TreatmentSunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent SarcomasPhase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue SarcomaObservation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue SarcomaGlutamine in Preventing Oral Mucositis in Patients Receiving Chemotherapy for SarcomaIfosfamide and Doxorubicin, Radiation Therapy, and/or Surgery in Treating Young Patients With Localized Soft Tissue SarcomaBevacizumab and Radiation Therapy for SarcomasSorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent SarcomaImatinib Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma or Bone SarcomaSurgery Followed by Chemotherapy in Treating Young Patients With Soft Tissue SarcomaGenetic Study of Patients and Families With Diaphyseal Medullary Stenosis With Malignant Fibrous Histiocytoma of the Bone
P1050
P5166
Q61921044-23B13850-A9D0-401A-9DC4-4BC177831B6CQ61980179-26CC8BF8-A303-469D-A8C4-3E25C19FFB75Q62105049-C68CDBC5-1B20-454B-81CD-511EF9B77172Q63322723-7BC05F46-C644-4AD5-8141-AA68AC005C84Q63404590-CB95D040-4D30-4A4E-9696-B2CF096E6899Q63592611-786F98B7-584C-4E4C-AC28-1F846052B265Q63807954-A90700DD-E6DC-4CEC-8AF0-04B3E74BF938Q64048442-AAAF376E-E077-4C8F-885D-16339B891650Q64352987-6ECE3852-2FFD-4CED-9765-99F6041FE002Q64597826-6FE7EE9A-E690-4406-B149-1C5619AFD9D3Q64599760-381F3425-0B56-4CD4-8F0C-A5BB7009AEA7Q64678551-D4BFCB40-172F-4629-9C8D-140BCEBAFAADQ64720984-FD0BED82-2382-49D8-9EAE-4CC3DA7B55D9Q65371653-0D2D0506-B67F-4151-A983-72562B1FAAACQ65380309-9B667586-F0A6-48F7-AC2C-1E6D7469CA15Q65382968-8F138161-7764-424E-8CF6-BA2B63CCCE5CQ65385806-E0B91C27-C2F4-456C-A647-4E21D23267E2Q65388816-AB7AA9A7-5A5B-450D-B994-3B719BB46967Q65390081-9A98B1A8-3D7D-42D0-9ED6-607727E30B7DQ65390109-CCFB1281-8C55-4434-83DC-4C4392C4D437Q65475382-CD9B2029-C6AA-4480-A6F5-41B055FEDDABQ65542174-C9E11A1A-D07D-4E93-9CBD-A7216AF45F74Q66036283-F6DDD876-0366-419A-A35E-30EB3FB2DD06Q66038412-EDAE0D5A-78C5-4837-8817-6FB33A9B20C4Q66059912-0E4171F2-897C-49DE-BC1C-6A30E97D318A
P1050
description
Human disease
@en
Krankheit
@de
malattia
@it
tumeur
@fr
مرض يصيب الإنسان
@ar
name
histiocitoma
@es
histiocytoma
@en
histiocytome
@fr
ohistiocitoma
@ru
ورم المنسجات
@ar
type
label
histiocitoma
@es
histiocytoma
@en
histiocytome
@fr
ohistiocitoma
@ru
ورم المنسجات
@ar
altLabel
Histiocytoma
@en
prefLabel
histiocitoma
@es
histiocytoma
@en
histiocytome
@fr
ohistiocitoma
@ru
ورم المنسجات
@ar
P2888
P486
P1748
P1995
P2892
P31
P373
Histiocytoma
P3841
HP:0012315
P486
P492
P5270
MONDO:0005509
P672
C04.557.450.565.590.425